alexa Lymphoma | Hong Kong| PDF | PPT| Case Reports | Symptoms | Treatment

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences
Relevant Topics
  • Lymphoma

    Lymphoma is a form of cancer that affects the immune system - specifically, it is a cancer of immune cells called lymphocytes, a type of white blood cell. There are two broad types of lymphoma and many subtypes.The two types of lymphoma are described as: Hodgkin's or non-Hodgkin's.Use this page for comprehensive and easy-to-follow information about lymphoma - both non-Hodgkin's and Hodgkin's lymphoma.

  • Lymphoma

    The symptoms typically involve painless swelling of the lymph nodes (glands), often in the neck or armpits where these nodes are concentrated. Swelling may also occur in the groin and abdomen, although some people You may be familiar with this sign because the lymph nodes in the neck (commonly referred to as "glands") can become swollen during infections such as the cold - but here the swelling subsides, whereas it does not in cancer

  • Lymphoma

    Treatment is usually effective and leads to a period of remission, where the patient is free from the disease Indolent (low-grade) lymphoma may relapse though, requiring further treatment. In some cases, an indolent lymphoma can become aggressive, which necessitates more aggressive treatment Typically people with indolent lymphoma live for a long time and have a good quality of life Some people may not require any treatment 

  • Lymphoma

    The overall five-year relative survival rate for leukemia has more than quadrupled since 1960. From 1960 to 1963, the five-year relative survival rate among whites (only data available) with leukemia was 14 percent the overall relative survival rate was 60.3 percent.From 2004-2010, the five-year relative survival rates overall were CML - 59.9 percent CLL - 83.5 percent AML - 25.4 percent overall and 66.3 percent for children and adolescents younger than 15 years ALL - 70 percent overall, 91.8 percent for children and adolescents younger than 15 years, and 93 percent for children younger than 5 years.

Expert PPTs
Speaker PPTs

High Impact List of Articles

Conference Proceedings